NICE guidance does not recommend aromatase inhibitors for treating erectile dysfunction
Newman CB, Blaha MJ, Boord JB, Cariou B, Chait A, Fein HG, et al
This condition, now called metabolic dysfunction-associated steatotic liver disease (MASLD), can progress to liver inflammation, scarring, and eventually liver failure
It reflects the reality that individual biology creates enormous variation in drug response
As a consequence, levels of adherence are lower than for people with diabetes, as demonstrated by another study that applied the same metric of adherence to people using GLP-1s to treat obesity: 40.1% for Ozempic (semaglutide, Novo Nordisk), 31.5% for weekly injectable Wegovy and just 15% for daily injectable Saxenda (liraglutide, Novo Nordisk).10 This suggests that greater expectation management is required to maintain users faith in the value and purpose of what they are doing